The effect of omega-3 on Diabet

The effect of omega-3 fatty acids on Glycemic control in type 2 diabetic patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210928052621N1

Enrollment

188

Registered

2023-09-04

Start date

2023-09-11

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabet type 2. Dietary counseling and surveillance

Interventions

Intervention 1: Intervention group: In the intervention group, 3000 mg of omega-3 fatty acid (3 capsules of 1000 mg in the morning, noon, and night from Dana Pharmaceutical Company under the brand na

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Suffering from type 2 diabetes Consent to participate in the intervention Age between 40 and 70 years Under the care of Farhikhtegan Hospital bmi less than 30

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
FBS. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after receiving the Omega 3 drug. Method of measurement: Blood Test.;HbA1C. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after receiving the Omega 3 drug. Method of measurement: Blood Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Panahian

Islamic Azad University

ar_panahian@yahoo.com+98 21 4484 5163

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026